Aurobindo Pharma | ARBP - Interest Expense On Debt

Stock Price
1,413.80
Daily Change
-22.10 -1.54%
Monthly
8.11%
Yearly
16.09%
Q2 Forecast
1,382.70

Aurobindo Pharma reported INR927.7M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Cipla INR 140.3M 8.5M Dec/2025
Divis Laboratories Ltd INR 60M 30M Dec/2025
Dr.Reddys Laboratories INR 944M 37M Dec/2025
Hindustan Unilever INR 880M 410M Dec/2025
Sun Pharmaceuticals INR 998.6M 250.6M Sep/2025
UPL INR 7.74B 210M Dec/2025